Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1

Molecular Pharmacology

Volumn 59, Issue 2, 2001, Pages 263-268

  Siegel, David ^a   Anwar, Adil ^a   Winski, Shannon L ^a   Kepa, Jadwiga K ^a   Zolman, Kathryn L ^a   Ross, David ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; POLYUBIQUITIN; PROLINE; PROTEASOME; PROTEASOME INHIBITOR; RECOMBINANT PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SERINE;

ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME DEGRADATION; GENETIC POLYMORPHISM; HALF LIFE TIME; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN PURIFICATION; RABBIT; RETICULOCYTE LYSATE;

EID: 0035135690     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.2.263     Document Type: Article

References (36)

1. Assembly of the 26S complex that degrades proteins ligated to ubiquitin is accompanied by the formation of ATPase activity
2. Role of NAD(P)H:quinone oxidoreductase (DT-Diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin
3. The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems
4. Molecular characterization of binding of substrates and inhibitors to DT-diaphorase: Combined approach involving site-directed mutagenesis, inhibitor-binding analysis, and computer modeling
5. ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation
6. Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: Use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci
7. DT-Diaphorase
8. Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens
9. Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: Species comparison and structural changes with substrate binding and release
10. Increased half-life of mu immunoglobulin mRNA during mouse B cell development increases its abundancy
11. Properties and reaction mechanism of DT diaphorase from rat liver
12. Ethnic variation in the prevalence of a common NAD(P)H:quinone oxidoreductase polymorphism and its implications for anticancer chemotherapy
13. Prevalence of the inactivating 609C->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia
14. Selective inhibitors of the proteasome dependent and vacuaolar pathways of protein degradation in Saccharomyces cerevisiae
15. Mutation of DT-diaphorase in human breast cancer cell lines
16. The three dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy. Mechanism of the two electron reduction
17. DT-Diaphorase as a quinone reductase: A cellular control device against semiquinone and superoxide radical formation
18. Protein measurement with the folin phenol reagent
19. DT-Diaphorase and cytochrome B5 reductase in human lung and breast tumours
20. Transfection of COS-1 cells with DT-diaphorase cDNA: Role of a base change at position 609
21. NAD(P)H quinone oxidoreductase activity is the principal determinant of Betalapachone cytotoxicity
22. Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking
23. 609C->T mutation and rapid fractional excretion of chlorzoxazone
24. Cytosolic NAD(P)H:quinone acceptor oxidoreductase in human normal and tumor tissue. Effects of cigarette smoking and alcohol
25. Increased frequency of a null allele for NAD(P)H:quinone oxidoreductase in patients with urological malignancies
26. Purification by cibacron blue F3GA dye affinity chromatography and comparison of NAD(P)H:quinone reductase (E. C. 1.6.99.2) from rat liver cytosol and microsomes
27. Bioreductive activation of mitomycin C by DT-diaphorase
28. The reduction of α-tocopherolquinone by human NAD(P)H:quinone oxidoreductase: The role of α-tocopherol hydroquinone as a cellular antioxidant
29. Immunohistochemical detection of NAD-(P)H:quinone oxidoreductase in human lung and lung tumors
30. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1
31. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: Characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity
32. Characterization of a polymorphism in NAD(P)H:quinone oxidoreductase (DT-diaphorase)
33. The role of NAD(P)H:quinone reductase (EC 1.6.99.2 DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9
34. A lack of a functional NAD(P)H:quinone oxidoreductase allele Is selectively associated with pediatric leukemias that have MLL fusions
35. A new screening system for NAD(P)H:quinone oxidoreductase(NQO1)-directed antitumor quinones. Identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent